首页 > 最新文献

Journal of Infection and Public Health最新文献

英文 中文
Circular genome of human bocavirus 1 associated with high load of viral DNA, positive antigen and increased risk of severe pneumonia in children 人类波卡病毒1型环状基因组与病毒DNA高负荷、抗原阳性和儿童重症肺炎风险增加相关
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2026-01-16 DOI: 10.1016/j.jiph.2026.103156
Kexiang Zhang , Ri De , Zeng Li , Yanpeng Xu , Zhenzhi Han , Runan Zhu , Yu Sun , Liping Jia , Dongmei Chen , Yutong Zhou , Qi Guo , Yao Yao , Xiaolin Ma , Shuang Liu , Chunmei Zhu , Dong Qu , Linqing Zhao

Background

Human bocavirus 1 (HBoV1) causes acute respiratory infections (ARIs) in children, but its diagnosis is complicated by prolonged viral shedding. There are indications that the detection of a circular genome in a clinical specimens may be associated with acute infection.

Methods

Respiratory specimens collected from pediatric patients with ARIs during January 2021 to July 2024 were screened by a duplex qPCR, which was developed to distinguish circular genome from total viral genomes and evaluated by nested PCR and antigen test. Clinical data were collected from patients with single HBoV1 infection to reveal the association of circular genome with ARIs and the severity of pneumonia.

Results

Among 520 specimens positive for HBoV1 DNA, 206 (39.61 %) were positive for circular genomes as determined by duplex qPCR, with the median load of total genomes 1010.08 (IQR 109.26, 1010.62) copies/mL significantly higher than 107.81 (IQR 106.88, 108.60) copies/mL in the circular genome negative group (p < 0.0001). In the antigen-positive group, the positive rate for circular genomes was 78.57 % (44/56), significantly higher than 34.29 % (108/315) observed in the antigen-negative group. Among patients single positive for HBoV1, the circular genome-positive group (n = 106) showed more severe clinical manifestations and required more intensive treatment. Logistic regression analysis identified the circular genome as a strong independent risk factor for severe pneumonia (OR = 6.38, AUC = 0.82).

Conclusion

Circular genome of HBoV1 associated with high load of viral DNA, positive antigen and severe pneumonia in children may serve as a biomarker for acute HBoV1 infection and severe pneumonia.
人类bocavavirus 1 (HBoV1)在儿童中引起急性呼吸道感染(ARIs),但由于病毒长期脱落,其诊断变得复杂。有迹象表明,在临床标本中检测到环状基因组可能与急性感染有关。方法对2021年1月至2024年7月收集的急性呼吸道感染患儿呼吸道标本,采用区分环状基因组和总病毒基因组的双工qPCR方法进行筛选,并采用巢式PCR和抗原检测进行评价。收集单例HBoV1感染患者的临床数据,以揭示环基因组与ARIs和肺炎严重程度的关联。结果520份HBoV1 DNA阳性标本中,环状基因组阳性206份(39.61 %),总基因组中位数负荷1010.08 (IQR 109.26, 1010.62) copies/mL显著高于环状基因组阴性组的107.81 (IQR 106.88, 108.60) copies/mL (p <; 0.0001)。抗原阳性组环状基因组阳性率为78.57 %(44/56),显著高于抗原阴性组34.29 %(108/315)。在HBoV1单一阳性患者中,环状基因组阳性组(n = 106)临床表现更严重,需要更强化的治疗。Logistic回归分析发现,环状基因组是严重肺炎的一个强大的独立危险因素(OR = 6.38, AUC = 0.82)。结论儿童HBoV1环状基因组与病毒DNA高负荷、抗原阳性和重症肺炎相关,可作为急性HBoV1感染和重症肺炎的生物标志物。
{"title":"Circular genome of human bocavirus 1 associated with high load of viral DNA, positive antigen and increased risk of severe pneumonia in children","authors":"Kexiang Zhang ,&nbsp;Ri De ,&nbsp;Zeng Li ,&nbsp;Yanpeng Xu ,&nbsp;Zhenzhi Han ,&nbsp;Runan Zhu ,&nbsp;Yu Sun ,&nbsp;Liping Jia ,&nbsp;Dongmei Chen ,&nbsp;Yutong Zhou ,&nbsp;Qi Guo ,&nbsp;Yao Yao ,&nbsp;Xiaolin Ma ,&nbsp;Shuang Liu ,&nbsp;Chunmei Zhu ,&nbsp;Dong Qu ,&nbsp;Linqing Zhao","doi":"10.1016/j.jiph.2026.103156","DOIUrl":"10.1016/j.jiph.2026.103156","url":null,"abstract":"<div><h3>Background</h3><div>Human bocavirus 1 (HBoV1) causes acute respiratory infections (ARIs) in children, but its diagnosis is complicated by prolonged viral shedding. There are indications that the detection of a circular genome in a clinical specimens may be associated with acute infection.</div></div><div><h3>Methods</h3><div>Respiratory specimens collected from pediatric patients with ARIs during January 2021 to July 2024 were screened by a duplex qPCR, which was developed to distinguish circular genome from total viral genomes and evaluated by nested PCR and antigen test. Clinical data were collected from patients with single HBoV1 infection to reveal the association of circular genome with ARIs and the severity of pneumonia.</div></div><div><h3>Results</h3><div>Among 520 specimens positive for HBoV1 DNA, 206 (39.61 %) were positive for circular genomes as determined by duplex qPCR, with the median load of total genomes 10<sup>10.08</sup> (IQR 10<sup>9.26</sup>, 10<sup>10.62</sup>) copies/mL significantly higher than 10<sup>7.81</sup> (IQR 10<sup>6.88</sup>, 10<sup>8.60</sup>) copies/mL in the circular genome negative group (<em>p</em> &lt; 0.0001). In the antigen-positive group, the positive rate for circular genomes was 78.57 % (44/56), significantly higher than 34.29 % (108/315) observed in the antigen-negative group. Among patients single positive for HBoV1, the circular genome-positive group (n = 106) showed more severe clinical manifestations and required more intensive treatment. Logistic regression analysis identified the circular genome as a strong independent risk factor for severe pneumonia (OR = 6.38, AUC = 0.82).</div></div><div><h3>Conclusion</h3><div>Circular genome of HBoV1 associated with high load of viral DNA, positive antigen and severe pneumonia in children may serve as a biomarker for acute HBoV1 infection and severe pneumonia.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103156"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A call for global surveillance and coordinated action 高毒力和耐碳青霉烯肺炎克雷伯菌:呼吁全球监测和协调行动。
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2026-01-08 DOI: 10.1016/j.jiph.2026.103141
Shital Ghogale, Ketaki Pathak
{"title":"Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: A call for global surveillance and coordinated action","authors":"Shital Ghogale,&nbsp;Ketaki Pathak","doi":"10.1016/j.jiph.2026.103141","DOIUrl":"10.1016/j.jiph.2026.103141","url":null,"abstract":"","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103141"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146125319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empowering active surveillance of Carbapenem-resistant Enterobacterales: Insights from one year of genomic surveillance 授权碳青霉烯抗性肠杆菌的主动监测:从一年的基因组监测的见解。
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2026-02-26 DOI: 10.1016/j.jiph.2026.103187
Greta Petazzoni , Stefano Gaiarsa , Irene Mileto , Angela Kuka , Marta Corbella , Cristina Merla , Antonio Piralla , Marina Ramus , Aurora Piazza , Vittoria Mattioni Marchetti , Roberta Migliavacca , Alba Muzzi , Patrizia Cambieri , Fausto Baldanti

Background

Healthcare-associated infections (HAIs) in Europe affect millions of patients annually, driving antimicrobial resistance and imposing significant economic burdens. Carbapenem-resistant Enterobacterales (CRE) are particularly concerning due to their ability to spread, making genomic surveillance essential for tracking their transmission.

Methods

From October 2022 to September 2023, we sequenced and analysed the genome of 340 CRE obtained from patients admitted to Fondazione IRCCS Policlinico San Matteo ( Italy). Sequencing was performed using a short-read approach and genomes were in-silico characterized to identify Sequence Types (STs), antimicrobial resistance and virulence determinants, and plasmid content. Moreover, a core SNP-based phylogeny was performed to identify potential epidemic clusters within the same clone.

Results

Among the 340 CRE isolated from surveillance (N = 234) and other clinical specimens (N = 106), 87.7% belonged to the Klebsiella genus, primarily K. pneumoniae (CR-Kp, N = 284). Escherichia coli (CR-Ec) accounted for 8.5% (N = 29); while the remaining species were Enterobacter spp. (N = 13) and Citrobacter spp. (N = 9). blaKPC and blaNDM gene variants were detected in 55.9% and 25.6% of CRE, respectively. The most prevalent CR-Kp clones were ST307, ST6668, ST258, and ST512, whereas ST131 was dominant among CR-Ec. Large epidemic clusters (ECs; ≥ 5 strains in each clade) were mainly found in CR-Kp associated with ST307 and ST6668, with 80.63% of CR-Kp grouped into nine ECs. Conversely, other species were observed as sporadic cases or within transmission clusters with limited spread.

Conclusion

Our comprehensive analysis of CRE circulation at HSM revealed that their dissemination was largely driven by highly successful clones, shedding light on several of them.
背景:欧洲医疗保健相关感染(HAIs)每年影响数百万患者,推动抗菌素耐药性并造成重大经济负担。碳青霉烯耐药肠杆菌(CRE)由于其传播能力特别令人担忧,因此基因组监测对于跟踪其传播至关重要。方法:从2022年10月至2023年9月,我们对来自意大利圣马泰奥基金会(Fondazione IRCCS Policlinico San Matteo)收治的340例CRE患者的基因组进行了测序和分析。测序采用短读法,并对基因组进行了计算机表征,以确定序列类型(STs)、抗菌素耐药性和毒力决定因素以及质粒含量。此外,还进行了基于核心snp的系统发育,以确定同一克隆中潜在的流行病聚集性。结果:监测分离到的340株CRE (N = 234)和其他临床标本(N = 106)中,克雷伯氏菌属占87.7%,以肺炎克雷伯氏菌(CR-Kp, N = 284)为主。大肠杆菌(CR-Ec)占8.5% (N = 29);其余菌种为肠杆菌(N = 13)和柠檬酸杆菌(N = 9)。在CRE中分别检测到55.9%和25.6%的blaKPC和blaNDM基因变异。CR-Kp无性系以ST307、ST6668、ST258和ST512最为普遍,而CR-Ec无性系以ST131为主。与ST307和ST6668相关的CR-Kp主要存在大流行聚集性(ECs,每个进化支≥5株),其中80.63%的CR-Kp归为9个ECs。相反,其他物种为散发病例或传播聚集性病例,传播有限。结论:我们对HSM的CRE循环进行了综合分析,发现它们的传播主要是由非常成功的克隆驱动的,从而揭示了其中一些克隆。
{"title":"Empowering active surveillance of Carbapenem-resistant Enterobacterales: Insights from one year of genomic surveillance","authors":"Greta Petazzoni ,&nbsp;Stefano Gaiarsa ,&nbsp;Irene Mileto ,&nbsp;Angela Kuka ,&nbsp;Marta Corbella ,&nbsp;Cristina Merla ,&nbsp;Antonio Piralla ,&nbsp;Marina Ramus ,&nbsp;Aurora Piazza ,&nbsp;Vittoria Mattioni Marchetti ,&nbsp;Roberta Migliavacca ,&nbsp;Alba Muzzi ,&nbsp;Patrizia Cambieri ,&nbsp;Fausto Baldanti","doi":"10.1016/j.jiph.2026.103187","DOIUrl":"10.1016/j.jiph.2026.103187","url":null,"abstract":"<div><h3>Background</h3><div>Healthcare-associated infections (HAIs) in Europe affect millions of patients annually, driving antimicrobial resistance and imposing significant economic burdens. Carbapenem-resistant <em>Enterobacterales</em> (CRE) are particularly concerning due to their ability to spread, making genomic surveillance essential for tracking their transmission.</div></div><div><h3>Methods</h3><div>From October 2022 to September 2023, we sequenced and analysed the genome of 340 CRE obtained from patients admitted to Fondazione IRCCS Policlinico San Matteo ( Italy). Sequencing was performed using a short-read approach and genomes were <em>in-silico</em> characterized to identify Sequence Types (STs), antimicrobial resistance and virulence determinants, and plasmid content. Moreover, a core SNP-based phylogeny was performed to identify potential epidemic clusters within the same clone.</div></div><div><h3>Results</h3><div>Among the 340 CRE isolated from surveillance (N = 234) and other clinical specimens (N = 106), 87.7% belonged to the <em>Klebsiella</em> genus, primarily <em>K. pneumoniae</em> (CR-Kp, N = 284). <em>Escherichia coli</em> (CR-Ec) accounted for 8.5% (N = 29); while the remaining species were <em>Enterobacter spp.</em> (N = 13) and <em>Citrobacter spp.</em> (N = 9). <em>bla</em><sub>KPC</sub> and <em>bla</em><sub>NDM</sub> gene variants were detected in 55.9% and 25.6% of CRE, respectively. The most prevalent CR-Kp clones were ST307, ST6668, ST258, and ST512, whereas ST131 was dominant among CR-Ec. Large epidemic clusters (ECs; ≥ 5 strains in each clade) were mainly found in CR-Kp associated with ST307 and ST6668, with 80.63% of CR-Kp grouped into nine ECs. Conversely, other species were observed as sporadic cases or within transmission clusters with limited spread.</div></div><div><h3>Conclusion</h3><div>Our comprehensive analysis of CRE circulation at HSM revealed that their dissemination was largely driven by highly successful clones, shedding light on several of them.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103187"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147355209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors, clinical outcomes of patients with Ceftazidime/Avibactam-resistant carbapenem-Resistant Klebsiella pneumoniae infection and its potential resistant mechanisms 头孢他啶/阿维巴坦耐碳青霉烯耐药肺炎克雷伯菌感染的危险因素、临床结局及其潜在耐药机制
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2026-01-31 DOI: 10.1016/j.jiph.2026.103161
Zhenchao Wu , Yanqiu Ma , Jiajia Zheng , Ping Yang , Ming Lu , Du Yipeng , Ning Shen

Background

Ceftazidime/avibactam (CZA) resistance (CZAr) poses critical challenges for the treatment of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. The early identification of high-risk populations is essential for controlling nosocomial transmission and guiding empirical therapy. This study aimed to systematically focus on the correlation between the clinical characteristics of patients and the microbial features of CZArCRKP.

Methods

We conducted a retrospective cohort study (January 2020-May 2023) of 97 patients with CRKP infection. Antimicrobial susceptibility testing and whole-genome sequencing (WGS) were used to analyze resistance phenotype-genotype correlations. Survival outcomes were evaluated using Kaplan–Meier analysis.

Results

CZArCRKP primarily caused lower respiratory (72.16 %) and urinary tract (16.49 %) infections, predominantly affecting elderly patients with comorbidities (81.4 %) or undergoing invasive procedures (63.9 %). Chronic renal failure combined with platelet counts > 149× 10⁹/L post-infection strongly predicted patients with CZArCRKP in pulmonary infections. NDM-1 gene carriage and OmpK36 mutations were associated with CZA resistance. CZA-treated patients demonstrated lower 14-day mortality rates.

Conclusion

We established the first integrated host-pathogen risk model for CZArCRKP and identified chronic renal failure and platelet count as key clinical predictors. NDM-1/OmpK36 mutations represents a clear mechanism of resistance. CZA use may improve the survival of selected patients with CRKP. These findings advance the surveillance and therapeutic strategies for multidrug-resistant infections.
头孢他啶/阿维巴坦(CZA)耐药(CZAr)对耐碳青霉烯肺炎克雷伯菌(CRKP)感染的治疗提出了严峻挑战。早期识别高危人群对控制院内传播和指导经验性治疗至关重要。本研究旨在系统探讨CZArCRKP患者临床特征与微生物特征的相关性。方法对97例CRKP感染患者进行回顾性队列研究(2020年1月- 2023年5月)。采用药敏试验和全基因组测序(WGS)分析耐药表型与基因型的相关性。使用Kaplan-Meier分析评估生存结果。结果sczarcrkp主要引起下呼吸道感染(72.16 %)和泌尿道感染(16.49 %),主要影响有合并症的老年患者(81.4 %)或有创手术患者(63.9 %)。慢性肾衰竭合并血小板计数>; 149× 10⁹/L感染后强烈预测肺部感染的CZArCRKP患者。NDM-1基因携带和OmpK36突变与CZA耐药相关。经cza治疗的患者14天死亡率较低。结论建立了首个CZArCRKP的综合宿主-病原体风险模型,并确定慢性肾功能衰竭和血小板计数是关键的临床预测因子。NDM-1/OmpK36突变代表了一个明确的耐药机制。使用CZA可能会提高CRKP患者的生存率。这些发现促进了多药耐药感染的监测和治疗策略。
{"title":"Risk factors, clinical outcomes of patients with Ceftazidime/Avibactam-resistant carbapenem-Resistant Klebsiella pneumoniae infection and its potential resistant mechanisms","authors":"Zhenchao Wu ,&nbsp;Yanqiu Ma ,&nbsp;Jiajia Zheng ,&nbsp;Ping Yang ,&nbsp;Ming Lu ,&nbsp;Du Yipeng ,&nbsp;Ning Shen","doi":"10.1016/j.jiph.2026.103161","DOIUrl":"10.1016/j.jiph.2026.103161","url":null,"abstract":"<div><h3>Background</h3><div>Ceftazidime/avibactam (CZA) resistance (CZAr) poses critical challenges for the treatment of carbapenem-resistant <em>Klebsiella pneumoniae</em> (CRKP) infections. The early identification of high-risk populations is essential for controlling nosocomial transmission and guiding empirical therapy. This study aimed to systematically focus on the correlation between the clinical characteristics of patients and the microbial features of CZArCRKP.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study (January 2020-May 2023) of 97 patients with CRKP infection. Antimicrobial susceptibility testing and whole-genome sequencing (WGS) were used to analyze resistance phenotype-genotype correlations. Survival outcomes were evaluated using Kaplan–Meier analysis.</div></div><div><h3>Results</h3><div>CZArCRKP primarily caused lower respiratory (72.16 %) and urinary tract (16.49 %) infections, predominantly affecting elderly patients with comorbidities (81.4 %) or undergoing invasive procedures (63.9 %). Chronic renal failure combined with platelet counts &gt; 149× 10⁹/L post-infection strongly predicted patients with CZArCRKP in pulmonary infections. <em>NDM-1</em> gene carriage and <em>OmpK36</em> mutations were associated with CZA resistance. CZA-treated patients demonstrated lower 14-day mortality rates.</div></div><div><h3>Conclusion</h3><div>We established the first integrated host-pathogen risk model for CZArCRKP and identified chronic renal failure and platelet count as key clinical predictors. <em>NDM-1/OmpK36</em> mutations represents a clear mechanism of resistance. CZA use may improve the survival of selected patients with CRKP. These findings advance the surveillance and therapeutic strategies for multidrug-resistant infections.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103161"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calls for papers: Antimicrobial resistance and one health: interdisciplinary strategies to address a global challenge – Virtual special issue 征文:抗菌素耐药性和一种健康:应对全球挑战的跨学科战略——虚拟特刊
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2025-12-27 DOI: 10.1016/j.jiph.2025.103122
{"title":"Calls for papers: Antimicrobial resistance and one health: interdisciplinary strategies to address a global challenge – Virtual special issue","authors":"","doi":"10.1016/j.jiph.2025.103122","DOIUrl":"10.1016/j.jiph.2025.103122","url":null,"abstract":"","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103122"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146172262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-driven policy recommendations for dengue prevention and control in Thailand: A mixed-methods study 泰国社区驱动的登革热预防和控制政策建议:一项混合方法研究
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2026-02-01 DOI: 10.1016/j.jiph.2026.103166
Chawarat Rotejanaprasert , Ngamphol Soonthornworasiri , Lokachet Tanasugarn , Amorn Leelarasamee , Kulkanya Chokephaibulkit , Udomsak Narkkul , Peeradone Srichan , Khuanchai Koompapong , Piroon Mootsikapun , Winai Ratanasuwan , Saranath Lawpoolsri

Background

The World Health Organization roadmap targets the eradication of dengue, a neglected tropical disease. Community participation is crucial for successful control efforts, which must transcend technical solutions to engage and motivate the public. This study examined the needs, perceptions, and emotional drivers underpinning dengue prevention efforts and recommended tailored policies to control dengue in varied settings.

Methods

This mixed-methods study, using a triangulation design, was conducted in four geographical regions of Thailand between November 2023 and April 2024. Quantitative surveys were administered to 664 community members and 430 public health personnel, complemented by 10 focus group discussions (FGDs) with community members, 16 FGDs, and 23 in-depth interviews (IDIs) with public health personnel. Logistic regression was used to examine factors associated with dengue control practices, while qualitative data were analyzed thematically. Findings from both components were integrated during interpretation to enhance the robustness of conclusions.

Results

Integrated quantitative and qualitative findings showed that most participants practiced active dengue prevention. Social support strongly influenced preventive behaviors (OR 19.81; 95 % CI 8.53–46.03), whereas demographic factors and perceived susceptibility or severity were not significant. Higher practice levels were observed among participants in the northeast and health personnel aged ≥ 50 years. Qualitative data reinforced these findings, emphasizing the vital role of village health volunteers and challenges such as limited participation, low risk perception, poor sanitation, and cultural barriers shaping vaccine hesitancy.

Conclusion

Effective dengue control requires context-specific, evidence-based strategies that strengthen community participation, empower village health volunteers, and enhance vector control. Early warning systems and intersectoral collaboration are vital in high-risk areas, while transparent, culturally tailored communication can improve vaccine acceptance. These findings provide evidence to guide policy toward sustainable, community-centered dengue prevention and control.
背景:世界卫生组织路线图的目标是消灭登革热,这是一种被忽视的热带病。社区参与对于成功的控制工作至关重要,必须超越技术解决方案,让公众参与并激励公众。这项研究调查了登革热预防工作的需求、观念和情感驱动因素,并建议了在不同环境下控制登革热的有针对性的政策。方法:该混合方法研究于2023年11月至2024年4月在泰国的四个地理区域进行,采用三角测量设计。对664名社区成员和430名公共卫生人员进行了定量调查,并与社区成员进行了10次焦点小组讨论(fgd), 16次焦点小组讨论(fgd), 23次与公共卫生人员进行了深入访谈(IDIs)。使用逻辑回归来检查与登革热控制措施相关的因素,同时对定性数据进行主题分析。在解释过程中整合了两个组成部分的发现,以增强结论的稳健性。结果:综合定量和定性研究结果显示,大多数参与者都采取了积极的登革热预防措施。社会支持强烈影响预防行为(OR 19.81; 95 % CI 8.53-46.03),而人口因素和感知易感性或严重程度不显著。在东北地区的参与者和年龄≥ 50岁的卫生人员中观察到较高的实践水平。定性数据强化了这些发现,强调了乡村卫生志愿者的重要作用和挑战,如参与有限、风险认知低、卫生条件差以及形成疫苗犹豫的文化障碍。结论:有效的登革热控制需要针对具体情况的循证战略,加强社区参与,赋予乡村卫生志愿者权力,并加强媒介控制。预警系统和部门间合作在高风险地区至关重要,而透明的、有文化针对性的沟通可以提高疫苗的接受度。这些发现为指导可持续、以社区为中心的登革热预防和控制政策提供了证据。
{"title":"Community-driven policy recommendations for dengue prevention and control in Thailand: A mixed-methods study","authors":"Chawarat Rotejanaprasert ,&nbsp;Ngamphol Soonthornworasiri ,&nbsp;Lokachet Tanasugarn ,&nbsp;Amorn Leelarasamee ,&nbsp;Kulkanya Chokephaibulkit ,&nbsp;Udomsak Narkkul ,&nbsp;Peeradone Srichan ,&nbsp;Khuanchai Koompapong ,&nbsp;Piroon Mootsikapun ,&nbsp;Winai Ratanasuwan ,&nbsp;Saranath Lawpoolsri","doi":"10.1016/j.jiph.2026.103166","DOIUrl":"10.1016/j.jiph.2026.103166","url":null,"abstract":"<div><h3>Background</h3><div>The World Health Organization roadmap targets the eradication of dengue, a neglected tropical disease. Community participation is crucial for successful control efforts, which must transcend technical solutions to engage and motivate the public. This study examined the needs, perceptions, and emotional drivers underpinning dengue prevention efforts and recommended tailored policies to control dengue in varied settings.</div></div><div><h3>Methods</h3><div>This mixed-methods study, using a triangulation design, was conducted in four geographical regions of Thailand between November 2023 and April 2024. Quantitative surveys were administered to 664 community members and 430 public health personnel, complemented by 10 focus group discussions (FGDs) with community members, 16 FGDs, and 23 in-depth interviews (IDIs) with public health personnel. Logistic regression was used to examine factors associated with dengue control practices, while qualitative data were analyzed thematically. Findings from both components were integrated during interpretation to enhance the robustness of conclusions.</div></div><div><h3>Results</h3><div>Integrated quantitative and qualitative findings showed that most participants practiced active dengue prevention. Social support strongly influenced preventive behaviors (OR 19.81; 95 % CI 8.53–46.03), whereas demographic factors and perceived susceptibility or severity were not significant. Higher practice levels were observed among participants in the northeast and health personnel aged ≥ 50 years. Qualitative data reinforced these findings, emphasizing the vital role of village health volunteers and challenges such as limited participation, low risk perception, poor sanitation, and cultural barriers shaping vaccine hesitancy.</div></div><div><h3>Conclusion</h3><div>Effective dengue control requires context-specific, evidence-based strategies that strengthen community participation, empower village health volunteers, and enhance vector control. Early warning systems and intersectoral collaboration are vital in high-risk areas, while transparent, culturally tailored communication can improve vaccine acceptance. These findings provide evidence to guide policy toward sustainable, community-centered dengue prevention and control.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103166"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whole blood gene expression to assess disease severity of omicron-associated acute encephalitis and croup in children: A transcriptomic and immune profiling study 全血基因表达评估组粒相关急性脑炎和儿童组的疾病严重程度:转录组学和免疫分析研究
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2026-02-10 DOI: 10.1016/j.jiph.2026.103181
Chong-Wei Huang , Wei-Chao Liao , Ian Yi-Feng Chang , En-Wei Hsing , Chung-Guei Huang , Jainn-Jim Lin , Kuang-Lin Lin , Cheng-Hsun Chiu , Chih-Ho Chen , Jen-Han Chen , Wen-I Lee , Yu-Chia Hsieh

Background

The Omicron variant of SARS-CoV-2 has caused severe complications in children, including encephalitis/encephalopathy and croup, yet the underlying pathogenic mechanisms remain unclear. Transcriptome analysis could provide insights into immune responses and guide clinical management strategies.

Methods

We conducted a case-control cohort study of COVID-19 patients across two medical centers in Taiwan from April 17 to November 7, 2022. Blood RNA sequencing was used to analyze differences in gene expression and functional pathways between cases of encephalitis/encephalopathy or croup of varying severity and controls with mild febrile disease. We applied computational analyses to identify transcriptomic signatures linked to COVID-19 associated encephalitis/encephalopathy.

Results

This study included 61 patients diagnosed with SARS-CoV-2 infection: 29 with mild febrile disease, 14 with croup, and 18 with encephalitis/encephalopathy. More differentially expressed genes were identified in encephalitis/encephalopathy (n = 834) than in croup (n = 185). Functional enrichment analysis revealed coordinated upregulation of myeloid leukocyte, neutrophil, and macrophage pathways in encephalitis/encephalopathy, accompanied by downregulation of HLA class II expression, antigen presentation, and T-cell activation, with changes tracking disease severity. CIBERSORT analysis revealed increased activated dendritic cells and reduced naïve CD4 T cells, CD8 T cells, naïve B cells, and NK cells. Croup patients showed reduced antigen presentation and low T cell receptor signaling. Gene expression profiles differentiated encephalitis/encephalopathy from mild febrile disease with a positive predictive value of 95.3 %.

Conclusion

Future interventions aiming at innate immune dysregulation, such as neutrophil inhibition, addressing macrophage activation, and enhancing T-cell responses, could play a promising role in improving outcomes for children infected with emerging, virulent SARS-CoV-2 variants.
背景:SARS-CoV-2的组粒变异在儿童中引起了严重的并发症,包括脑炎/脑病和群,但潜在的致病机制尚不清楚。转录组分析可以深入了解免疫反应并指导临床管理策略。方法:我们于2022年4月17日至11月7日在台湾两个医疗中心对COVID-19患者进行病例对照队列研究。采用血液RNA测序分析脑炎/脑病病例或不同严重程度组与轻度发热病对照之间基因表达和功能通路的差异。我们应用计算分析来确定与COVID-19相关脑炎/脑病相关的转录组特征。结果:本研究纳入61例确诊为SARS-CoV-2感染的患者,其中轻度发热29例,群发14例,脑炎/脑病18例。脑炎/脑病组差异表达基因(n = 834)多于对照组(n = 185)。功能富集分析显示,脑炎/脑病中髓系白细胞、中性粒细胞和巨噬细胞通路的协同上调,伴随着HLAⅱ类表达、抗原呈递和t细胞活化的下调,并随疾病严重程度的变化而变化。CIBERSORT分析显示,活化的树突状细胞增加,naïve CD4 T细胞、CD8 T细胞、naïve B细胞和NK细胞减少。组患者表现出抗原呈递减少和T细胞受体信号传导低。基因表达谱将脑炎/脑病与轻度发热性疾病区分开来,阳性预测值为95.3% %。结论:未来针对先天免疫失调的干预措施,如中性粒细胞抑制、解决巨噬细胞激活和增强t细胞反应,可能在改善新出现的致命性SARS-CoV-2变体感染儿童的预后方面发挥有希望的作用。
{"title":"Whole blood gene expression to assess disease severity of omicron-associated acute encephalitis and croup in children: A transcriptomic and immune profiling study","authors":"Chong-Wei Huang ,&nbsp;Wei-Chao Liao ,&nbsp;Ian Yi-Feng Chang ,&nbsp;En-Wei Hsing ,&nbsp;Chung-Guei Huang ,&nbsp;Jainn-Jim Lin ,&nbsp;Kuang-Lin Lin ,&nbsp;Cheng-Hsun Chiu ,&nbsp;Chih-Ho Chen ,&nbsp;Jen-Han Chen ,&nbsp;Wen-I Lee ,&nbsp;Yu-Chia Hsieh","doi":"10.1016/j.jiph.2026.103181","DOIUrl":"10.1016/j.jiph.2026.103181","url":null,"abstract":"<div><h3>Background</h3><div>The Omicron variant of SARS-CoV-2 has caused severe complications in children, including encephalitis/encephalopathy and croup, yet the underlying pathogenic mechanisms remain unclear. Transcriptome analysis could provide insights into immune responses and guide clinical management strategies.</div></div><div><h3>Methods</h3><div>We conducted a case-control cohort study of COVID-19 patients across two medical centers in Taiwan from April 17 to November 7, 2022. Blood RNA sequencing was used to analyze differences in gene expression and functional pathways between cases of encephalitis/encephalopathy or croup of varying severity and controls with mild febrile disease. We applied computational analyses to identify transcriptomic signatures linked to COVID-19 associated encephalitis/encephalopathy.</div></div><div><h3>Results</h3><div>This study included 61 patients diagnosed with SARS-CoV-2 infection: 29 with mild febrile disease, 14 with croup, and 18 with encephalitis/encephalopathy. More differentially expressed genes were identified in encephalitis/encephalopathy (n = 834) than in croup (n = 185). Functional enrichment analysis revealed coordinated upregulation of myeloid leukocyte, neutrophil, and macrophage pathways in encephalitis/encephalopathy, accompanied by downregulation of HLA class II expression, antigen presentation, and T-cell activation, with changes tracking disease severity. CIBERSORT analysis revealed increased activated dendritic cells and reduced naïve CD4 T cells, CD8 T cells, naïve B cells, and NK cells. Croup patients showed reduced antigen presentation and low T cell receptor signaling. Gene expression profiles differentiated encephalitis/encephalopathy from mild febrile disease with a positive predictive value of 95.3 %.</div></div><div><h3>Conclusion</h3><div>Future interventions aiming at innate immune dysregulation, such as neutrophil inhibition, addressing macrophage activation, and enhancing T-cell responses, could play a promising role in improving outcomes for children infected with emerging, virulent SARS-CoV-2 variants.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103181"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146213361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comprehensive review of resistome profiles in ocular pathogens: Insights into Pseudomonas aeruginosa and emerging resistance trends 眼部病原菌的抗药组研究综述:铜绿假单胞菌和新出现的耐药趋势。
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2026-02-12 DOI: 10.1016/j.jiph.2026.103183
Raghav Krishnan Kulandaivelu , Aditi Roy , Soham Roy , J.S. Amith Velavan , Reddysai Amudala , Debraj Joel Das Adhikari , Karan S.V. , Sudha Ramaiah , Anand Anbarasu
Eye infections are a significant area of microbial adaptation and therapeutic challenge, as antibiotic resistance threatens vision. In the last ten years, our knowledge of the ocular resistome has expanded through genomics and molecular epidemiology. An analysis of global evidence from 2015 to 2025 on the resistance architecture of major ocular pathogens will be presented, with a focus on Pseudomonas aeruginosa (P. aeruginosa). The organism shows remarkable genomic flexibility by incorporating intrinsic resistance elements, biofilm-mediated tolerance, and by acquiring ARGs such as blaVIM, blaGES, QnrVC and RmtB by horizontal transfer. According to researchers, Staphylococcus aureus (S. aureus), Streptococcus pneumoniae (S. pneumoniae), and Acinetobacter baumannii (A. baumannii) have evolved mechanisms of drug resistance. Geographic analysis shows regional disparities, particularly in South Asia and North America, which are associated with antibiotic use and clinical exposure. To prevent the emergence of ocular antimicrobial resistance, there’s an urgent need for rapid molecular diagnostics, genomic-based surveillance, and responsible antimicrobial stewardship.
眼睛感染是微生物适应和治疗挑战的重要领域,因为抗生素耐药性威胁视力。在过去的十年里,我们对眼部抵抗组的了解通过基因组学和分子流行病学得到了扩展。将介绍2015年至2025年全球主要眼部病原体耐药结构的证据分析,重点是铜绿假单胞菌(P. aeruginosa)。通过整合内在抗性元件、生物膜介导的耐受性,以及通过水平转移获得blaVIM、blaGES、QnrVC和RmtB等arg,该生物表现出显著的基因组灵活性。据研究人员介绍,金黄色葡萄球菌(S. aureus)、肺炎链球菌(S. pneumoniae)和鲍曼不动杆菌(A. baumannii)已经进化出了耐药机制。地理分析显示区域差异,特别是在南亚和北美,这与抗生素使用和临床接触有关。为了防止眼部抗菌素耐药性的出现,迫切需要快速分子诊断、基于基因组的监测和负责任的抗菌素管理。
{"title":"A comprehensive review of resistome profiles in ocular pathogens: Insights into Pseudomonas aeruginosa and emerging resistance trends","authors":"Raghav Krishnan Kulandaivelu ,&nbsp;Aditi Roy ,&nbsp;Soham Roy ,&nbsp;J.S. Amith Velavan ,&nbsp;Reddysai Amudala ,&nbsp;Debraj Joel Das Adhikari ,&nbsp;Karan S.V. ,&nbsp;Sudha Ramaiah ,&nbsp;Anand Anbarasu","doi":"10.1016/j.jiph.2026.103183","DOIUrl":"10.1016/j.jiph.2026.103183","url":null,"abstract":"<div><div>Eye infections are a significant area of microbial adaptation and therapeutic challenge, as antibiotic resistance threatens vision. In the last ten years, our knowledge of the ocular resistome has expanded through genomics and molecular epidemiology. An analysis of global evidence from 2015 to 2025 on the resistance architecture of major ocular pathogens will be presented, with a focus on <em>Pseudomonas aeruginosa</em> (<em>P. aeruginosa)</em>. The organism shows remarkable genomic flexibility by incorporating intrinsic resistance elements, biofilm-mediated tolerance, and by acquiring ARGs such as <em>bla</em><sub>VIM</sub>, <em>bla</em><sub>GES</sub>, QnrVC and RmtB by horizontal transfer. According to researchers, <em>Staphylococcus aureus</em> (<em>S. aureus</em>)<em>, Streptococcus pneumoniae</em> (<em>S. pneumoniae)</em>, and <em>Acinetobacter baumannii (A. baumannii)</em> have evolved mechanisms of drug resistance. Geographic analysis shows regional disparities, particularly in South Asia and North America, which are associated with antibiotic use and clinical exposure. To prevent the emergence of ocular antimicrobial resistance, there’s an urgent need for rapid molecular diagnostics, genomic-based surveillance, and responsible antimicrobial stewardship.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103183"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146213364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of changes in lactate dehydrogenase (LDH) levels in predicting COVID-19 severity and mortality: A biomarker analysis 乳酸脱氢酶(LDH)水平变化在预测COVID-19严重程度和死亡率中的作用:一项生物标志物分析
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2026-01-15 DOI: 10.1016/j.jiph.2026.103153
Seyed Hassan Saadat , Behzad Einollahi , Hadi Norouzi , Mohammad Farjami , Nematollah Jonaidi Jafari , Shahla Afsharpeyman , Fahime Shahjooie , Ali Bahrami Far , Kiavash Hushmandi

Background

Lactate dehydrogenase (LDH) has emerged as a potential biomarker for COVID-19 severity, but the diagnostic value of its dynamic changes (ΔLDH) remains unclear. This study aimed to determine the predictive value of ΔLDH for clinical outcomes in hospitalized patients with COVID-19.

Methods

We performed a retrospective cohort study of 5635 adults with confirmed COVID-19, analyzing LDH measurements. The patients were stratified by ΔLDH quartiles (Q1-Q4). Multivariable logistic regression was used to assess the associations with mortality and ICU admission, while ROC analysis was used to determine the predictive performance.

Results

A U-shaped relationship was observed, with both extreme reductions (Q1: ΔLDH ≤ -196 U/L) and elevations (Q4: ΔLDH ≥ 108 U/L) predicting adverse outcomes. Q4 patients had a higher risk of mortality (aOR = 6.72, 95 % CI: 5.31–8.51) and a higher risk of ICU admission (aOR = 6.63, 95 % CI: 5.26–8.36) compared to Q1. ΔLDH revealed excellent discrimination for mortality (AUC = 0.78) with an optimal cutoff at 181.5 U/L (sensitivity = 66.7 %, specificity = 88.9 %).

Conclusion

ΔLDH is a powerful, independent predictor of COVID-19 severity, revealing a novel U-shaped risk pattern. The 181.5 U/L threshold offers clinically actionable guidance for risk stratification. These findings support the incorporation of serial LDH monitoring into COVID-19 management protocols.
背景:乳酸脱氢酶(LDH)已成为COVID-19严重程度的潜在生物标志物,但其动态变化的诊断价值尚不清楚(ΔLDH)。本研究旨在确定ΔLDH对COVID-19住院患者临床结局的预测价值。方法:对5635例确诊COVID-19的成年人进行回顾性队列研究,分析LDH测量值。患者按ΔLDH四分位数(Q1-Q4)分层。采用多变量logistic回归评估与死亡率和ICU入院的关系,采用ROC分析确定预测效果。结果:观察到U型关系,极端降低(Q1: ΔLDH≤ -196 U/L)和升高(Q4: ΔLDH≥108 U/L)预测不良结局。Q4患者的死亡风险(aOR = 6.72, 95 % CI: 5.31-8.51)和ICU入院风险(aOR = 6.63, 95 % CI: 5.26-8.36)高于Q1。ΔLDH对死亡率有很好的鉴别(AUC = 0.78),最佳截止值为181.5 U/L(敏感性= 66.7 %,特异性= 88.9 %)。结论:ΔLDH是一个强大的、独立的COVID-19严重程度预测因子,揭示了一种新的u型风险模式。181.5 U/L阈值为风险分层提供了临床可操作的指导。这些发现支持将LDH连续监测纳入COVID-19管理方案。
{"title":"The role of changes in lactate dehydrogenase (LDH) levels in predicting COVID-19 severity and mortality: A biomarker analysis","authors":"Seyed Hassan Saadat ,&nbsp;Behzad Einollahi ,&nbsp;Hadi Norouzi ,&nbsp;Mohammad Farjami ,&nbsp;Nematollah Jonaidi Jafari ,&nbsp;Shahla Afsharpeyman ,&nbsp;Fahime Shahjooie ,&nbsp;Ali Bahrami Far ,&nbsp;Kiavash Hushmandi","doi":"10.1016/j.jiph.2026.103153","DOIUrl":"10.1016/j.jiph.2026.103153","url":null,"abstract":"<div><h3>Background</h3><div>Lactate dehydrogenase (LDH) has emerged as a potential biomarker for COVID-19 severity, but the diagnostic value of its dynamic changes (ΔLDH) remains unclear. This study aimed to determine the predictive value of ΔLDH for clinical outcomes in hospitalized patients with COVID-19.</div></div><div><h3>Methods</h3><div>We performed a retrospective cohort study of 5635 adults with confirmed COVID-19, analyzing LDH measurements. The patients were stratified by ΔLDH quartiles (Q1-Q4). Multivariable logistic regression was used to assess the associations with mortality and ICU admission, while ROC analysis was used to determine the predictive performance.</div></div><div><h3>Results</h3><div>A U-shaped relationship was observed, with both extreme reductions (Q1: ΔLDH ≤ -196 U/L) and elevations (Q4: ΔLDH ≥ 108 U/L) predicting adverse outcomes. Q4 patients had a higher risk of mortality (aOR = 6.72, 95 % CI: 5.31–8.51) and a higher risk of ICU admission (aOR = 6.63, 95 % CI: 5.26–8.36) compared to Q1. ΔLDH revealed excellent discrimination for mortality (AUC = 0.78) with an optimal cutoff at 181.5 U/L (sensitivity = 66.7 %, specificity = 88.9 %).</div></div><div><h3>Conclusion</h3><div>ΔLDH is a powerful, independent predictor of COVID-19 severity, revealing a novel U-shaped risk pattern. The 181.5 U/L threshold offers clinically actionable guidance for risk stratification. These findings support the incorporation of serial LDH monitoring into COVID-19 management protocols.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103153"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-exposure prophylaxis with favipiravir among household close contacts to confirmed COVID-19 cases: A cluster-randomized trial (PEPfavi) COVID-19确诊病例家庭密切接触者的法匹拉韦暴露后预防:一项聚类随机试验(PEPfavi)
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-04-01 Epub Date: 2026-01-14 DOI: 10.1016/j.jiph.2026.103150
Taweegrit Siripongboonsitti , Teerapat Ungtrakul , Kriangkrai Tawinprai , Krongkwan Niemsorn , Kunsuda Punjachaipornpol , Worrawat Sangwipasnapaporn , Natcha Wattanapokasilp , Marisa Muadchimkaew , Saowanee Wongpatcharawarakul , Kamonwan Soonklang , Nithi Mahanonda

Background

Household transmission of SARS-CoV-2 remains a key driver of community spread, with secondary attack rates in Thai households reaching approximately 50 %. There is limited evidence supporting the efficacy of antiviral post-exposure prophylaxis (PEP) in this context.

Methods

The phase 2/3, open-label, (1:1) cluster-randomized controlled trial in Thailand, 168 household close contacts from 76 index cases were enrolled to receive either favipiravir-PEP (FPV-PEP) (1600–2000 mg/day for 7 days) or usual care. The efficacy of FPV-PEP was investigated in preventing SARS-CoV-2 infection after contact with index cases.

Results

The incidence of confirmed SARS-CoV-2 infection was lower in the FPV-PEP group than in the usual care group (7.32 % vs. 14.47 %), although the difference was not statistically significant. A trend toward fewer early positive rapid diagnostic test results on day 3 was observed in the FPV-PEP group. Symptom development was less frequent among FPV-PEP recipients, with fewer cases of fever, rhinorrhea, and myalgia. A significantly higher probability of remaining asymptomatic and delayed symptom onset was observed in the FPV-PEP group. No participants developed severe COVID-19 or required hospitalization.

Conclusion

FPV-PEP was associated with a lower incidence of fever, rhinorrhea, and myalgia among household contacts. While a reduction in secondary transmission was observed, it did not reach statistical significance. Further large-scale studies are warranted to clarify its role in preventing household transmission.
SARS-CoV-2的家庭传播仍然是社区传播的主要驱动因素,泰国家庭的二次发病率约为50% %。在这种情况下,支持抗病毒暴露后预防(PEP)有效性的证据有限。方法在泰国进行2/3期、开放标签、(1:1)聚类随机对照试验,选取76例家庭密切接触者中的168例,分别接受favipirvir - pep (FPV-PEP) (1600 ~ 2000 mg/d,连用7 d)或常规护理。观察FPV-PEP在接触指示病例后预防SARS-CoV-2感染的效果。结果FPV-PEP组确诊SARS-CoV-2感染发生率低于常规护理组(7.32 %比14.47 %),但差异无统计学意义。在FPV-PEP组中,观察到第3天早期阳性快速诊断试验结果较少的趋势。FPV-PEP受者的症状发展较少,发热、鼻流和肌痛的病例较少。在FPV-PEP组中观察到明显更高的剩余无症状和延迟症状发作的可能性。没有参与者出现严重的COVID-19或需要住院治疗。结论fpv - pep与家庭接触者发热、流鼻、肌痛发生率较低有关。虽然观察到二次传播的减少,但没有达到统计学意义。有必要进一步进行大规模研究,以阐明其在预防家庭传播方面的作用。
{"title":"Post-exposure prophylaxis with favipiravir among household close contacts to confirmed COVID-19 cases: A cluster-randomized trial (PEPfavi)","authors":"Taweegrit Siripongboonsitti ,&nbsp;Teerapat Ungtrakul ,&nbsp;Kriangkrai Tawinprai ,&nbsp;Krongkwan Niemsorn ,&nbsp;Kunsuda Punjachaipornpol ,&nbsp;Worrawat Sangwipasnapaporn ,&nbsp;Natcha Wattanapokasilp ,&nbsp;Marisa Muadchimkaew ,&nbsp;Saowanee Wongpatcharawarakul ,&nbsp;Kamonwan Soonklang ,&nbsp;Nithi Mahanonda","doi":"10.1016/j.jiph.2026.103150","DOIUrl":"10.1016/j.jiph.2026.103150","url":null,"abstract":"<div><h3>Background</h3><div>Household transmission of SARS-CoV-2 remains a key driver of community spread, with secondary attack rates in Thai households reaching approximately 50 %. There is limited evidence supporting the efficacy of antiviral post-exposure prophylaxis (PEP) in this context.</div></div><div><h3>Methods</h3><div>The phase 2/3, open-label, (1:1) cluster-randomized controlled trial in Thailand, 168 household close contacts from 76 index cases were enrolled to receive either favipiravir-PEP (FPV-PEP) (1600–2000 mg/day for 7 days) or usual care. The efficacy of FPV-PEP was investigated in preventing SARS-CoV-2 infection after contact with index cases.</div></div><div><h3>Results</h3><div>The incidence of confirmed SARS-CoV-2 infection was lower in the FPV-PEP group than in the usual care group (7.32 % vs. 14.47 %), although the difference was not statistically significant. A trend toward fewer early positive rapid diagnostic test results on day 3 was observed in the FPV-PEP group. Symptom development was less frequent among FPV-PEP recipients, with fewer cases of fever, rhinorrhea, and myalgia. A significantly higher probability of remaining asymptomatic and delayed symptom onset was observed in the FPV-PEP group. No participants developed severe COVID-19 or required hospitalization.</div></div><div><h3>Conclusion</h3><div>FPV-PEP was associated with a lower incidence of fever, rhinorrhea, and myalgia among household contacts. While a reduction in secondary transmission was observed, it did not reach statistical significance. Further large-scale studies are warranted to clarify its role in preventing household transmission.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 4","pages":"Article 103150"},"PeriodicalIF":4.0,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146102486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Infection and Public Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1